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For antibody discovery and engineering, yeast surface display (YSD) of antigen-binding
fragments (Fabs) and coupled fluorescence activated cell sorting (FACS) provide intact
paratopic conformations and quantitative analysis at the monoclonal level, and thus
holding great promises for numerous applications. Using anti-TNFα mAbs Infliximab,
Adalimumab, and its variants as model Fabs, this study systematically characterized
complementary approaches for the optimization of Fab YSD. Results suggested that by
using divergent promoter GAL1-GAL10 and endoplasmic reticulum (ER) signal peptides
for co-expression of light chain and heavy chain-Aga2 fusion, assembled Fabs were
functionally displayed on yeast cell surface with sigmoidal binding responses toward
TNFα. Co-expression of a Hsp70 family molecular chaperone Kar2p and/or protein-
disulfide isomerase (Pdi1p) significantly improved efficiency of functional display (defined
as the ratio of cells displaying functional Fab over cells displaying assembled Fab).
Moreover, fusing ER retention sequences (ERSs) with light chain also enhanced Fab
display quality at the expense of display quantity, and the degree of improvements
was correlated with the strength of ERSs and was more significant for Infliximab than
Adalimumab. The feasibility of affinity maturation was further demonstrated by isolating
a high affinity Fab clone from 1:103 or 1:105 spiked libraries.
Keywords: yeast surface display, Fab, divergent promotor, ER retention sequence, molecular chaperone
INTRODUCTION
Monoclonal antibodies (mAbs) represent the fastest growing class of therapeutics in the last
decades. By the end of 2018, at least 116 mAb-based biopharmaceutical products are active on
the market (Walsh, 2018; DeFrancesco, 2019). Notably, mAbs occupies seven spots out of the top
ten best-selling drugs in 2018 (Urquhart, 2019). As 54 new mAbs in late-stage clinical trials are
under regulatory review, it is expected that mAb-based products will continue to dominate the
biopharmaceutical approvals in the near future. From the biotechnology viewpoint, an essential
development step is the affinity maturation of lead mAbs to achieve high potencies desirable
for therapeutic practices. Following the generation of combinatorial libraries, a high-throughput
selection/screening method needs to be exploited to isolate mAb variants with improved affinities.
Compared to selection approaches, which rely on overall binding strength such as phage panning,
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fluorescence activated cell sorting (FACS) is advantageous
by providing quantitative analysis of each library member.
During subsequent rounds of sorting, the concentration of a
fluorophore-labeled antigen can be fine-tuned in a real-time
manner, leading to efficiently distinguish high affinity clones
from others. In addition, the multiparameter nature of FACS
allows to normalize the difference on antibody expression levels
among cells and/or various antibody clones. Accordingly, a dual
color sorting with one channel for antibody expression and the
other for antigen binding has been proven highly effective for
enriching affinity improved clones (Feldhaus et al., 2003; van den
Beucken et al., 2003).
For FACS, recombinant antibodies or their fragments must
be present on cell surface. Compared to mammalian cells, yeast
has been widely used for antibody surface display due to its
low cost, ease to handle, and facile construction of antibody
libraries (Boder and Wittrup, 1997; Pepper et al., 2008). Derived
from human immunoglobulin G (IgG), the design of single-
chain variable fragment (scFv) links a heavy chain variable
domain (VH) with its associated light chain variable domain
(VL) via a flexible linker. As the smallest human antibody
fragment with binding function, scFv can be efficiently displayed
on yeast cell surface such as by fusion with a-agglutinin aga2
(Boder and Wittrup, 1997). Consequently, yeast surface display
(YSD) of scFv achieved great successes for antibody discovery
and engineering using either immunized or naïve/synthetic
libraries (Feldhaus et al., 2003; Miller et al., 2008). However,
the conformation of VH and VL domains in scFv format
may not be the same as in its natural IgG, in which the
heavy and light chains also interact through their constant
heavy 1 (CH1) and constant light (CL) domains. Although
such conformational variations are usually subtle, its impact
on binding affinity can be substantial and problematic for
affinity maturation studies (Casadevall and Janda, 2012). In
fact, it is not uncommon that significant potency loss happens
when an affinity matured scFv clone is converted back to its
associated IgG (Steinwand et al., 2014; Yang et al., 2018). As
the antigen-binding fragment (Fab) contains half heavy chain
(VH-CH1) and entire light chain (VL-CL), this format can
reserve VH and VL domains in their intact conformations.
Therefore, it is argued that the best combination for affinity
maturation is to display Fabs on yeast surface and to screen
by FACS.
Since the initial studies of YSD in 1990s (Boder and Wittrup,
1997), recent researches have demonstrated the feasibility of
displaying Fabs (Rosowski et al., 2018; Wang et al., 2018),
and full-length IgGs (Rhiel et al., 2014) on yeast cell surface.
These developments apply different technologies including bi-
directional promoter design for co-expression (Rosowski et al.,
2018), type II restriction enzymes for library construction
(Roth et al., 2019), immobilized ZZ domain for surface
display (Rhiel et al., 2014), and leucine-zipper interactions
for Fab assembly (Wang et al., 2018). It has been proven
that Fab was more reliable than scFv for YSD (Sivelle
et al., 2018), and Fab YSD was suitable for antibody affinity
maturation (Yang et al., 2018). Despite these tremendous
advances, systematic study for Fab YSD optimization is
still lacking.
One characteristic of protein production in yeast cells is that
various molecular chaperons exist in the endoplasmic reticulum
(ER) to facilitate the protein folding and post-translational
modifications. Kar2p, also known as BiP, is amajormember of the
Hsp70 chaperone family, which binds to unfolded polypeptide
chains and mediates protein folding within the ER (Rose et al.,
1989; Valkonen et al., 2003; Hernandez-Elvira and Torres-
Quiroz, 2018). Only correctly folded proteins can be released
from Kar2p, while abnormally folded or improperly assembled
proteins are retained by Kar2p for later degradation. In addition,
ER-associated protein disulfide isomerase (Pdi1p) catalyzed the
disulfide bonds formation in eukaryotic cells (Farquhar et al.,
1991; Niu et al., 2016; Beal et al., 2019). These molecular
chaperons are crucial for the Fab assembly, whose efficiency
depends on the correct folding of VH-CH1 and VL-CL domains
as well as the formation of intra- and inter-molecular disulfide
bonds. Moreover, ER retention, mediated by characteristic ER
retention sequence (ERS), is a mechanism that ensures only
properly folded/assembled proteins are exported from the ER
to the Golgi (Munro and Pelham, 1987). This phenomenon
provides a means of quality control during protein synthesis,
maturation and assembly, because misfolded or incorrectly
assembled proteins are retained in the ER and targeted for
degradation (Ellgaard et al., 1999). Our previous work on
characterization of HDEL-type ERS suggested that the ERS
sequence HDEL exhibited a protein ER retention ability 2-fold
stronger than that of KDEL but was 50% of FEHDEL, the
strongest endogenous ERS in Saccharomyces cerevisiae (Munro
and Pelham, 1987; Mei et al., 2017). Further systematic study
of all endogenous ERS indicated that an engineered sequence
WEHDEL could confer 2-fold stronger retention ability than
FEHDEL. Building on above knowledge, using anti-tumor
necrosis factor α (TNFα) mAbs Infliximab (Keane et al.,
2001), Adalimumab (D2E7), and its variants (Rajpal et al.,
2005) as model Fabs, this study characterized the impacts of
molecular chaperons Kar2p and Pdi1p and four ERSs, i.e.,
WEHDEL, FEHDEL, HDEL, and KDEL, on Fab YSD efficiency.
In addition, the feasibility of Fab maturation through high-
throughput screening was demonstrated by FACS sorting of large
spiked libraries.
MATERIALS AND METHODS
Construction of Fab and scFv Yeast
Surface Display Vectors
Genes encoding VH-CH1 and VL-CL fragments (Salfeld et al.,
2003; Rajpal et al., 2005) were chemically synthesized, amplified
by PCR and cloned to PstI/EcoRI sites and BamHI/XhoI sites,
respectively, on pESD (Yi et al., 2015) to generate pESD-
Fab. pESD-HC (heavy chain only) and pESD-LC (light chain
only) were also generated as controls. Fragments encoding
Adalimumab variant scFvs, VL-(G4S)3-VH, were assembled by
overlapping PCR and cloned to PstI/EcoRI sites on pESD to
generate pESD-scFv. Kar2p and Pdi1p wild-type (wt) genes were
amplified by PCR using the genome of S. cerevisiae EBY100 as the
templates and fused with protomer GAL1 region by overlapping
PCR. Using Kar2p and Pdi1p wt genes as the templates, their
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mutants were generated through site mutagenesis. Obtained
GAL1-Kar2p/Pdi1p cassettes were cloned to KpnI/BglII sites on
pESD-Fab to give pESD-Fab-Kar2p/Pdi1p. Additional GAL1-
Kar2p cassette was cloned to SacI site on pESD-Fab-Pdi1p to give
pESD-Fab-Pdi1p-Kar2p. ERSs were introduced at C-termini of
light chains by extension PCR and cloned to pESD-Fab to give
pESD-Fab-ERS. All cloning works were performed in Escherichia
coli XL-Gold and confirmed by DNA sequencing.
Expression and Purification of TNFα-His6
Gene of human TNFα (NCBI ID: 7124) was chemically
synthesized, cloned to pET-28a, and transformed to E. coli BL21
(DE3) cells for culture in LB medium at 37◦C. When OD600
reached 0.6–0.8, cells were induced with 0.5mM IPTG at 18◦C
for 20 h. After induction, cells were collected and resuspended
in lysis buffer containing 50mM Tris (pH 8.0), 150mM NaCl,
0.5 mg/mL lysozyme, 1mM PMSF, and 10mM imidazole for 1 h
on ice, followed by sonication. Cell debris was then removed
by centrifugation at 10,000 ×g at 4◦C for 20min, and the
supernatant containing TNFα-His6 was subjected to Ni-NTA
affinity purification at 4◦C (Qiagen, Valencia, CA, USA). Purity
of produced TNFα-His6 was tested by SDS-PAGE, and its
concentration was measured by UV absorbance.
Flow Cytometry Analysis of Displayed Fabs
and scFvs on Yeast Cell Surface
Generated yeast surface display plasmids were transformed to
S. cerevisiae EBY100 competent cells (Cooper and Hausman,
2000). Transformed cells were cultivated in SD-CAA medium
(20 g/L D-glucose, 6.7 g/L yeast nitrogen base, 5 g/L casamino
acids, 5.4 g/L Na2HPO4, 8.6 g/L NaH2PO4·H2O, pH 7.4) at
30◦C with shaking at 230 rpm. When OD600 reached 0.5–1.0,
cells were collected by centrifugation at 3,000 ×g for 2min
and inoculated to SG-CAA medium (20 g/L galactose, 6.7 g/L
yeast nitrogen base, 5 g/L casamino acids, 5.4 g/L Na2HPO4,
8.6 g/L NaH2PO4·H2O, pH 7.4). After induction at 18
◦C for
48 h, cells were harvested by centrifugation, washed three times
with PBS (pH 7.4), supplemented with 0.5% BSA and 1mM
EDTA, and re-suspended as 0.1 OD600 cells per 20 µL PBS
(pH 7.4), 0.5% BSA. For Fab and scFv display analysis, cells
were incubated with 0.1µM anti-HA-FITC and/or 0.1µM anti-
FLAG-iFlor647 (GenScript, Nanjing, China) for 15min in dark.
Flow cytometry analysis was performed by using Beckman
Coulter CytoFLEX (Brea, CA) equipped with 488 and 633 nm
lasers and 525/40 and 660/20 nm band-pass filters. To test
binding function of cell surface displayed antibody fragments,
cells were incubated with 1 pM −20 nM purified TNFα-His6 at
25◦C for 30min and subsequently labeled with 0.1µManti-His6-
iFluor647 (GenScript, Nanjing, China). Percentages of TNFα+
cells were quantified by FACS. The cells carrying Fab heavy chain
(VH-CH1) without light chain and light chain (VL-CL) without
heavy chain were used as controls.
FACS Enrichment for High Affinity Fab
Clone From Spiked Libraries
Cells bearing Fab cb2-6 and Fab D2E7 display vectors were
mixed at 1:103 or 1:105 ratios. After cultivation and induction,
mixed cells were labeled with TNFα-His6 of predetermined
concentrations, and subsequently labeled with 0.1µM anti-His6-
iFluor647 and 0.1µM anti-HA-FITC. Sorting was performed in
the single cell mode by using Beckman Coulter MoFlo XDP
flow cytometer (Brea, CA, USA) equipped with 488 and 633 nm
lasers and 525/40 and 660/20 nm band-pass filters. In each round,
107-109 cells were sorted, and 0.6–1.0% cells with the highest
FITC/iFluor647 double signals were collected. Collected cells
were cultivated in SD-CAA and induced in SG-CAA for the
next round of sorting. Aliquots of collected cells were also
recovered on SD-CAA plates for monoclonal analysis. Yeast
plasmids were extracted by using Zymolyase (Amsbio, Abingdon,
UK) and transformed into E. coli XL-Gold for amplification and
sequence analysis.
Yeast Total RNA Extract and qRT-PCR
After galactose induction, total RNA was extracted from yeast
cell samples by using RNAiso kit (TaKaRa Bio, Kusatsu, Japan).
Reverse transcription was performed by using PrimeScript II
first-strand cDNA synthesis kit (TaKaRa Bio) with Random 6
mers. The cDNA levels of Kar2p and Pdi1p were then analyzed
with CFX real-time PCR (Bio-Rad, Hercules, CA, USA). Relative
expression levels against endogenous Taf10 were determined
with efficiency correction and associated technical errors were
calculated. The final results were normalized by the relative
mRNA levels of Kar2p and Pdi1p in EBY100 cells.
RESULTS
Design for Fab Yeast Surface Display
For successful display of a Fab, its heavy chain (VH-CH1) and
light chain (VL-CL) need to be co-expressed. In our design, a
divergent GAL1-GAL10 promoter derived from previous studies
(West et al., 1987; Boder et al., 2005; Jiang and Boder, 2010)
is exploited by cloning Fab heavy chain and light chain at
downstream of GAL10 and GAL1, respectively (Figure 1A).
Therefore, in the presence of galactose, expression of both chains
will be induced simultaneously. Yeast endoplasmic reticulum
(ER) signal sequences are included at N-termini of both chains
for their translocation and secretory expression. Once translated,
Fab assembly between heavy and light chains, especially via the
intermolecular disulfide connecting C-termini of CH1 and CL, is
critical for its binding function (Padlan et al., 1986). Since protein
disulfide-bond formation in eukaryotic cells mainly occurs in
ER (Frand et al., 2000), targeting ER via signal sequences also
enhances Fab assembly. For surface display, VH-CH1 is fused
to the N-terminus of Aga2p, which leads transportation to cell
surface through the a-agglutinin system by a disulfide linkage
to the cell wall-anchored Aga1p (Boder and Wittrup, 1997).
In addition, a FLAG tag and a HA tag are introduced to the
heavy and light chain expression cassettes, respectively, for facile
detections (Figure 1A).
Display of Assembled Fabs on Yeast Cell
Surface
Fab display plasmids of anti-TNFα mAb D2E7 and its variants
were constructed and transformed into S. cerevisiae EBY100
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FIGURE 1 | Fab yeast surface display using a divergent promoter, ER-targeting signals, and Aga2 fusion. (A) pESD-Fab. Expression cassettes for light (VL-CL ) and
heavy (VH-CH1) chains were located downstream of GAL1-GAL10 promoter and endoplasmic reticulum (ER)-targeting signals. Light chain was fused with a HA tag,
and heavy chain was fused with a FLAG tag to the N-terminus of Aga2. (B) Validation of heavy chain display (left panels), light chain display (middle panels), and Fab
assembly (right panels) on yeast cell surface by flow cytometry. Expression was induced by 20 g/L galactose and cells were incubated with 0.1µM
anti-FLAG-iFluor647 and/or 0.1µM anti-HA-FITC antibodies. Fab display of Adalimumab (D2E7) and three variants were tested. Percentages of cells displaying
assembled Fabs were shown as Q2 (FLAG+/HA+ double positive). MFI, mean fluorescence intensity.
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cells. After cultivation and induction with 20 g/L galactose, cells
were analyzed by flow cytometry. To detect surface displayed
D2E7 heavy chain, which was fused with a FLAG tag to the
N-terminus of Aga2, cells were incubated with 0.1µM iFluor
647 conjugated anti-FLAG antibodies. FACS results showed
the successful anchoring of D2E7 heavy chain on yeast cell
surface, with 43% cells were FLAG+ (Figure 1B, left panel).
In contract, <0.6% cells bearing D2E7 light chain without
its heavy chain gene were FLAG+ Figure S1A). Similarly, the
display of HA-tagged D2E7 light chain was detected with 0.1µM
FITC conjugated anti-HA antibodies, and the results indicated
that 42% cells were HA+ (Figure 1B, middle panel), while
<0.4% cells bearing D2E7 heavy chain without its light chain
gene were HA+ (Figure S1B). In addition, <0.6% cells bearing
D2E7 light chain without its heavy chain gene were HA+
(Figure S1C). As D2E7 light chain expression cassette (VL-CL-
HA) did not possess the fusion partner Aga2 for anchoring,
display of D2E7 light chain on cell surface was presumably
caused by its Fab assembly between secreted light chain and
anchored heavy chain. To confirm the presence of both chains
on individual cells, induced cells were further dual labeled
with 0.1µM anti-FLAG-iFluor647 and 0.1µM anti-HA-FITC.
FACS results revealed that 41 ± 3% cells were FLAG+/HA+
double positive (Figure 1B, right panel), suggesting the display
of intermolecularly assembled D2E7 Fab. Display profiles of
D2E7 variants A1, cb1-3, and cb2-6 were also characterized
in the same approaches. Results suggested the similar display
levels for their heavy chains (42–45% FLAG+, Figure 1B, left
panel), their light chains (41–43% HA+, Figure 1B, middle
panel), and assembled Fabs (40–42% FLAG+/HA+ double
positive, Figure 1B, right panel). Notably, the mean fluorescence
intensity (MFI) of FLAG+ cells for cb1-3 was considerably less
than other tested Fab clones, suggesting that cb1-3 presumably
exhibited a lower expression level or less display efficiency of its
heavy chain.
Yeast Surface Displayed Fabs Were
Functional
To test binding functions of displayed D2E7 Fab and its variants,
human TNFα as a His6 tagged protein was recombinantly
produced in E. coli with a typical yield of 24mg purified
TNFα-His6 per liter of culture (Figure 2A). Cells bearing
D2E7 Fab construct were incubated with 1 pM−20 nM TNFα-
His6 followed by labeling with 0.1µM iFluor 647 conjugated
anti-His6 antibodies. In parallel, cells displaying D2E7 heavy
chain without its light chain was prepared as the control.
FACS results indicated that, when 20 nM TNFα-His6 was used,
only 0.5% of cells displaying D2E7 VH-CH1 were TNFα
+
(Figure 2B), suggesting that TNFα cannot be recognized by
either unassembled D2E7 heavy chain or yeast host cell
EBY100. In contrast, when D2E7 Fab was displayed, after
incubation with even 1 pM TNFα-His6, 5.3% cells were TNFα
+
(Figure 2C). The percentages of TNFα+ cells increased with
higher TNFα-His6 concentrations: 9.6% at 10 pM, 15% at 100
pM, 42% at 500 pM, and 46% at 1µM. The proportion of
TNFα+ cells became plateaued 55% when 5–20 nM TNFα-
His6 was applied, suggesting that under used culture and
induction conditions, 55% cells displayed functional D2E7
Fab. Plotting MFIs of TNFα+ cells over TNFα concentrations
demonstrated a sigmoidal correlation (Figure 2D). Dose-
response relationships on TNFα+ cell percentages and associated
MFIs were also measured for D2E7 variants A1, cb1-3, and
cb2-6. Results showed that ∼60% cells displayed functional
Fabs (Figure S2A) with expected sigmoidal curves between
MFIs and TNFα concentrations (Figures S2B–D). All these
results suggested that yeast surface displayed Fabs exhibited
their specific binding functions. Notably, when 1–100 pM
TNFα was used for cell labeling, MFIs of TNFα+ cells were
higher for variants cb1-3 and cb2-6 than D2E7 (Figure 2C,
Figure S2A), likely due to their improved affinities (Rajpal et al.,
2005).
Functional Display Efficiency Was
Improved by Co-expression of Molecular
Chaperones
As molecular chaperones in the ER assist folding of newly
synthesized proteins and prevent them from misfolding and/or
formation of aggregates (Hartl and Hayer-Hartl, 2002), we
next investigated the effects of a Hsp70 family member Kar2p
(Rose et al., 1989) on Fab surface display. To achieve co-
expression of Kar2p, its gene was cloned downstream of an
additional GAL1 promoter allowing its simultaneous induction
with galactose (Figure 3A). When EBY100 cells producing D2E7
Fab and Kar2p were labeled with anti-FLAG-iFluor647 or anti-
HA-FITC for detecting displayed heavy chain or light chain,
results revealed that co-expression of Kar2p in fact reduced
the percentages of cells displaying D2E7 heavy chain from
43 ± 2% to 25 ± 3% and cells displaying assembled D2E7
Fab from 40 ± 2% to 24 ± 2% (Figures 3B,C, Table S1).
MFIs of FLAG+ cells and HA+ cells also decreased when
Kar2p was co-expressed, suggesting that less amounts of heavy
chain and assembled Fab were displayed. To test the binding
function of displayed D2E7 Fab, induced cells were sequentially
labeled with 0.1 nM TNFα-His6 and 0.1µM anti-His6-iFluor647.
We used the ratio of TNFα+ percentage (cells displaying
functional Fab) over HA+ percentage (cells display assembled
Fab) to assess the efficiency of functional display. As results
shown in Figure 3D, co-expression of Kar2p increased the
efficiency of functional display of D2E7 Fab from 36 ± 2%
to 53± 1%.
To further evaluate the contribution of Kar2p on Fab
folding, we constructed inactive Kar2p mutants as controls.
As a Hsp70 chaperon, Kar2p’s nucleotide binding domain
carries ATPase activity to promote the interaction between
its substrate binding domain and unfolded protein substrates.
Therefore, by alanine substitutions of its ADP/ATP recognizing
residues E313/K316/S320 (Yan et al., 2011), or incorporating
the mutants of temperature-sensitive alleles C63Y/F196L/G417S
(Kimata et al., 2003), inactive Kar2pE313A/K316A/S320A and
Kar2pC63Y/F196L/G417S were generated. Same strategy was used
that co-expression of these Kar2p variants was under the
control of additional GAL1 promoter (Figure S3A). Co-
expression of Kar2p variants with D2E7 Fab resulted in drops
of cell percentages displaying D2E7 heavy chain (to 20 ±
2% and 23 ± 2% respectively) and assembled D2E7 Fab
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FIGURE 2 | Function characterizations of displayed Fab D2E7. (A) Recombinant production of human TNFα as a His6 tagged protein. (B) Flow cytometry analysis of
cells carrying the gene of Adalimumab (D2E7) heavy chain (VH-CH1) without its light chain. Expression was induced by 20 g/L galactose and cells were labeled with
20 nM TNFα-His6 and 0.1µM anti-His6-iFluor647. (C) Flow cytometry analysis of cells carrying D2E7 Fab display construct. Induced cells were labeled with 1 pM
−20 nM TNFα-His6 and 0.1µM anti-His6-iFluor647 for TNFα
+ cell quantification. (D) Sigmoidal curves depicting fluorescence intensities of TNFα+ cells as a function
of TNFα concentrations. Data are presented as mean ± S.E. (n = 3 independent experiments). MFI, mean fluorescence intensity.
(to 19 ± 2% and 21 ± 3%) (Figures S3B–D, Table S1). As
expected, these biochemically inactive Kar2p variants failed
to improve display efficiencies of functional D2E7 Fab, as
TNFα+ %/HA+ % ratios of 32 ± 4% and 38 ± 2% were
statistically indifferent from the D2E7 Fab producing cells
without chaperon co-expression.
Often as the rate-limiting step of protein folding in ER,
disulfide bond formation is critical for VH and VL domain
folding and their assembly to form a functional Fab. Therefore,
we further tested the effects of ER-associated protein-disulfide
isomerase (Pdi1p) on Fab surface display. Similar to Kar2p,
Pdi1p gene was cloned downstream of a GAL1 promoter for
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FIGURE 3 | Effects of molecular chaperones on Fab functional display. (A) Co-expression of Kar2p or Pdi1p was under the control of an additional GAL1 promoter on
pESD-Fab-Kar2p/Pdi1p. 0.1µM anti-FLAG-iFluor647, 0.1µM anti-HA-FITC, and 0.1 nM TNFα/0.1µM anti-His6-iFluor647 were used for labeling induced cells.
Display of heavy chain (FLAG+, B), display of light chain (HA+, C), efficiencies of functional display (defined as the percentage ratios between TNFα+ cells and HA+
cells, D) were presented as mean ± S.E. (n = 3 independent experiments) with Student’s t-test being performed, *P < 0.05.
its co-expression. Induced cells were labeled with anti-FLAG-
iFluor647 for detecting heavy chain display, anti-HA-FITC for
detecting Fab assembly, and TNFα-His6 and anti-His6-iFluor647
for detecting Fab function. Results indicated that when Pdi1p was
co-expressed, the cell percentage displaying D2E7 heavy chain
decreased from 43 ± 2% to 23 ± 1%, and the cell percentage
displaying D2E7 Fab decreased from 40 ± 2% to 23 ± 2%.
However, the functional display efficiency (defined as the ratio of
TNFα+ cells over HA+ cells) enhanced from 36± 2% to 70± 1%
(Figure 3). We also constructed Pdi1pC4S mutant by changing
the four catalytic cysteines of its thioredoxin-like domains to
serines (Tian et al., 2006; Wang et al., 2013), and Pdi1pC6S
mutant which carried two additional Cys->Ser substitutions
important for Pdi1p re-oxidation mediated by sulfhydryl oxidase
ER oxidoreductin 1 (Ero1p) (Frand and Kaiser, 2000; Niu et al.,
2016). Co-expression of inactive Pdi1pC4S/Pdi1pC6S with D2E7
Fab decreased cell percentage displaying its heavy chain and
assembled Fab without improvements on functional display
efficiencies (Figure S3, Table S1).
Infliximab is another therapeutic mAb targeting TNFα (Keane
et al., 2001), however its display as a scFv on yeast cell surface has
been proved difficult (Sivelle et al., 2018). To investigate whether
co-expression of Kar2p or Pdi1p can improve the display quality
of this challenging antibody clone, we constructed Infliximab Fab
yeast display and its co-expression vectors for Kar2p or Pdi1p
(Figure 3A). Similar to testing displayed D2E7 Fab, induced
cells were labeled and measured for Infliximab heavy chain
display (FLAG+ cells), Fab assembly (HA+ cells), and its function
(TNFα+ cells). Results showed that when Kar2p or Pdi1p was
co-expressed, while the percentages of cells displaying Infliximab
heavy chain decreased from 37 ± 3% to 20 ± 2% or 30 ± 2%,
and the percentages of cells displaying Infliximab Fab decreased
from 33± 1% to 23± 2% or 21± 2%, its efficiency of functional
display (TNFα+/HA+) increased from 15± 1% to 39± 2% or 53
± 2%, representing an 2.6- or 3.6-fold improvement, respectively
(Figures 3B–D, Table S1). Applying inactive Kar2p or Pdi1p
variants toward Infliximab Fab failed to improve its functional
display efficiencies (Figure S3, Table S1). Collectively, results
with two tested anti-TNFα clones suggested that molecular
chaperone Kar2p or Pdi1p significantly improved the quality of
displayed Fabs.
We also tested the effects of dual chaperones Kar2p and Pdi1p
co-expression on Fab YSD. Simultaneous co-expression of Kar2p
and Pdi1p was under the control of additional GAL1 promoters
on pESD-Fab-Pdi1p-Kar2p. Results indicated that the efficiencies
of functional display (TNFα+/HA+) were improved from 36 and
15% to 65 and 56% for D2E7 and Infliximab Fab, respectively,
while their light chain display amounts (as HA+) decreased from
40 and 33% to 20 and 16% (Figure S4). These results suggested
that, similar to the effects of Kar2p/Pdi1p alone, simultaneous
co-expression of these two chaperones improved the quality of
displayed Fabs at the expense of display quantity.
Functional Display Efficiency Was
Improved by Fusion With ER Retention
Sequences
We hypothesized that the ER retention sequence (ERS), a specific
short sequence that mediates protein retention in the ER (Munro
and Pelham, 1987; Mei et al., 2017), can extend the residence
time of Fab fragments in yeast ER and thus facilitate their proper
folding and assembly. Infliximab was our primary target because
of its relatively low yeast surface display efficiency (Table S1).
To determine the effect of ERS on Fab assembly, five ERSs of
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different strength were fused to the C-terminus of Infliximab
light chain (VL-CL) (Figure 4A). Induced cells were labeled with
anti-FLAGi-Fluor647 for detecting heavy chain display, anti-HA-
FITC for detecting Fab assembly, and TNFα-His6 and anti-His6-
iFluor647 for detecting Fab function. Similar to effects of tested
molecular chaperons (Figure 3), fusion with ERSs decreased
the surface display amounts of Infliximab heavy chain (FLAG+
cells) and assembled Fab (HA+ cells) (Figures 4B,C). However,
the percentages and MFIs of TNFα+ cells increased as ERS
strength increased (Figure 4D, Table S2). When 1 nM TNFα
was used for labeling, TNFα+ % increased with the efficiency
of functional Infliximab Fab display (TNFα+ cells / HA+ cells)
improved from 29 ± 2% without ERS, to 42 ± 2% with weak
ERS KDEL, and to 55 ± 4% and 64 ± 2% with strong ERSs
FEHDEL and WEHDEL, which represented a 2.0- and 2.3-fold
of improvement (Figure 4D). When labeled with 0.1 nM TNFα,
strong ERSs FEHDEL and WEHDEL comparably enhanced
functional display efficiency from 16 ± 1% to 33 ± 4% and 39
± 2%, with increased percentages and MFIs of TNFα+ cells.
Similar to Infliximab Fab, strong ERSs FEHDEL and WEHDEL
increased percentages and MFIs of TNFα+ cells and prompted
the functional display efficiency of D2E7 Fab for 1.5- and 1.9-
fold (Figure S5, Table S3), while weak ERSs, HDEL, and KDEL,
did not significantly affect display amounts or functional display
efficiencies. Overall, these results suggested that ERSs with high
retention strength improved the quality of yeast surface displayed
Fab, presumably due to extended residence time in the ER that
facilitated the formation of functional Fabs.
Enrichment of a High Affinity Fab Clone
From Spiked Libraries
To validate the feasibility of yeast surface Fab display for affinity
maturation, we mimicked the enrichment procedure with spiked
libraries. Compared to D2E7 scFv of 0.96 nM binding potency, its
variant cb2-6 scFv exhibited a reported affinity of 1.1 pM (Rajpal
et al., 2005). When 10 pM TNFα was used for labeling yeast
cells displaying D2E7 or cb2-6 Fab fragments, 9.6 or 20% cells
were TNFα+, respectively (Figure 2C), suggesting the possibility
to efficiently isolate cb2-6 from D2E7. Cells bearing cb2-6 Fab
gene were mixed with cells bearing D2E7 Fab gene at a ratio
1:103, and mixed cells were cultured for Fab expression. When
labeled with anti-FLAG-iFluor647 and anti-HA-FITC, 43% of
mixed cells were double positive indicating the successful display
of assembled Fabs (Figure 5A, left panel). In the first round of
FACS sorting (R1), 108 mixed cells were labeled with 0.1µM
anti-HA-FITC for detecting Fab assembly, and 1 nM TNFα-His6
plus 0.1µM anti-His6-iFluor647 for detecting TNFα binding.
Top 1.0% double positive clones, equivalent to 106 cells, were
collected. Similar FACS sorting was performed for six more
rounds with gradually reduced TNFα concentrations−100 pM
for R2, R3, and R4; 10 pM for R5 and R6; and finally 1 pM
for R7. For each round, 107 cells were sorted, and 5 × 104-7
× 104 cells with the highest signals on both Fab display and
TNFα binding were collected, equivalent to a selection gate of
0.60–0.72% (Figure 5A right panels). After certain rounds of
FACS, 10 clones were randomly picked for plasmid extraction
and DNA sequencing. Results indicated that the proportions of
cb2-6 clones were enriched to 10% post-R2 and 40% post-R4, and
reached to 80% post-R6 and 100% post-R7 (Figure 5C).
Successful isolation of cb2-6 from a 1:103 mixture encouraged
us to further test a more diluted library. The cb2-6 Fab cells
was mixed with the D2E7 Fab cells at a ratio of 1:105, a library
size needed for affinity maturation practices (Boder andWittrup,
1997). After induction for Fab expression and display, 43% of
cells were FLAG+ and HA+ double positive (Figure 5B, left
panel). Starting with this 1:105 spiked library, total nine rounds
of FACS were performed with decreasing TNFα concentrations
from 1 nM to 1 pM (Figures 5B,C). 109 mixed cells in R1 and
107-108 cells in later rounds were subjected for sorting with
selection gates of 0.60–0.90% for the cells with the highest double
signals on Fab display and TNFα binding. DNA sequencing
results of randomly picked post-sorting clones indicated that
cb2-6 increased its proportions to 20 and 40% post-R5 and
post-R6, and achieved dominancy of 70% post-R7 and finally
100% post-R9.
DISCUSSION
Currently, scFv is the antibody format commonly used for yeast
surface display (YSD) (Feldhaus and Siegel, 2004). Absent in
natural IgGs, the introduction of an artificial flexible peptide
linker, such as (G4S)3, between VH and VL domains can result
in paratopic conformations different from these of intact IgGs
(Gu et al., 2010). Although usually subtle and satisfactory for
antigen binding specificity, such conformational variations can
be troublesome for quantitative tasks such as affinity maturation
(Yang et al., 2018). Preserving the entire antigen binding region,
it has been suggested that Fab format retains the natural
conformations and thus were widely used for determining the
structures of antigen-antibody complex (Rothlisberger et al.,
2005). Additionally, Fabs were more suitable for YSD of various
antibody clones than scFvs (Sivelle et al., 2018). In this study,
scFvs of D2E7 and its mutants A1, cb1-3, and cb-6 were
also constructed for YSD (Figure S6A). Fluorescent staining for
surface display and followed FACS analysis showed that scFv
display levels varied from 31 to 46% (Figure S6B). In contrast, the
same Ab clones in their Fab format showed a similar Fab display
level with a narrow disparity of 41–43% (Figure 1B middle
panels). Furthermore, for Infliximab, only its Fab but not scFv
can be well-displayed on yeast cell surface (Sivelle et al., 2018).
Collectively, our results, consistent with others (Rosowski et al.,
2018; Wang et al., 2018; Yang et al., 2018), suggested that Fab is a
reliable and practicable format for YSD.
As the largest organelle of most eukaryotic cells, the
endoplasmic reticulum (ER) is the site where secretory
polypeptides fold into their correct three-dimensional
conformations, assemble into multi-subunit proteins, and
achieve covalent modifications such as disulfide bond formation
and initial glycosylation (Cooper and Hausman, 2000). By
fusing ER targeting signals upstream of both heavy and light
chains, Fabs successfully assembled and secreted for functional
surface display (Figure 1). Interestingly, only around 40–45% of
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FIGURE 4 | Effects of ER-retention sequence (ERS) on Infliximab Fab functional display. (A) ERSs were fused to the C-terminus of Infliximab light chain. 0.1µM
anti-FLAG-iFluor647, 0.1µM anti-HA-FITC, and 0.1–1.0 nM TNFα/0.1µM anti-His6-iFluor647 were used for labeling induced cells. Display of heavy chain (FLAG
+, B),
display of light chain (HA+, C), efficiencies of functional display (TNFα+ cells/HA+ cells, D) were presented as mean ± S.E. (n=3 independent experiments) with
Student’s t-test being performed, *P < 0.05. Effects of four ERSs (KDEL, HDEL, FEHDEL, and WEHDEL) were tested and compared to the clones without ERS.
FIGURE 5 | FACS enrichment for high affinity cb2-6 Fab clone from (A) 1:103 and (B) 1:105 spiked libraries. Cells carrying cb2-6 Fab gene were mixed with cells
carrying D2E7 Fab gene at an initial ratio of 1:103 or 1:105. After induction, mixed cells were incubated with TNFα-His6 of decreasing concentration over the rounds
and 0.1µM anti-His6-iFluor647. Sorting gates with their population percentages of representative rounds are shown. After each round of sorting, 10 clones were
randomly picked for plasmid extraction and DNA sequencing. (C) TNFα-His6 concentrations and post-round proportion of cb2-6 clones for each sorting rounds. n.d.,
not determined.
induced cells presented assembled Fabs on cell surface, which
could be attributed to either inefficient induction/expression or
improper domain folding/assembly. As folding and processing
of polypeptide chains in the ER is facilitated by the molecular
chaperones (Nishikawa et al., 2005; Buck et al., 2007), mounting
evidence suggests that the secretion of scFvs increased with
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co-expression of a wide range of molecular chaperones (Shusta
et al., 1998; Wentz and Shusta, 2007). In this study, a major
member of the Hsp70 chaperone family Kar2p or the ER-
associated Pdi1p was co-expressed to assist Fab production and
surface display. Consistent with Kar2p functions, our results
suggested that when assisted with Kar2p, the absolute amounts
of Fab display (percentage and MFIs of HA+ cells) decreased,
while functional display efficiency (defined as the ratio of cells
displaying functional Fab over cells displaying assembled Fab)
significantly improved for both D2E7 and Infliximab Fabs
(Figure 3). Similarly, co-expression of Pdi1p also improved
efficiency of functional display for Fabs in our study (Figure 3).
Notably, the improvements were more significant for Infliximab
(2.6- and 3.6-fold with Kar2p and Pdi1p) than D2E7 (1.5-
and 2.0-fold, respectively). When inactive Kar2p or Pdi1p
variants were co-expressed for comparison, Fab display amounts
were decreased without improvements on functional display
efficiencies (Figure S3, Table S1).
It was speculated that the co-expression of molecular
chaperons might increase the burden of transcriptional and
translational machinery in yeast cells. Indeed, qRT-PCR data
suggested that the mRNA levels of co-expressed Kar2p or
its variants were increased 9- to 16-fold compared to the
level of physiological Kar2p in the D2E7 and Infliximab Fab
producing cells (Figure S7A). Similarly, the mRNA levels of
co-expressed Pdi1p and its variants were increased 9- to 17-
fold over the background Pdi1p (Figure S7B). In our studies,
we also attempted to increase the Fab folding and assembly
efficiencies through retaining the light chain (VL-CL) longer
in the yeast ER by anchoring the ERS at its C-terminus
(Figure 4). Theoretically, the stronger ERS will increase the
retention time and concentration of VL-CL domain in the yeast
ER, thus enhancing the Fab folding and assembly efficiencies.
Consistently, our results suggested that fusion with ERSs
improved the quality of displayed Fabs (Figure 4, Figure S4).
However, it was also noticed that retaining the VL-CL domain
in the yeast ER decreased the display amounts of both heavy and
light chains along with the strength of ERS.
In summary, this study characterized four complementary
approaches for optimization of Fab yeast surface
display—divergent promoter, ER signal peptide, molecular
chaperones, and ER retention sequences. All these findings
highlighted the importance to consider tradeoffs between
quality and quantity of Fab yeast surface display for individual
antibody clones. Encouraged by the success of Fab YSD and
the feasibility of affinity maturation through FACS, current
efforts have been focusing on surveying novel approaches,
e.g., secretory organelle manipulation, to further improving
antibody YSD. As Fab YSD and coupled FACS provide intact
paratopic conformations and quantitative analysis at the
monoclonal level, we expect this technology holds great potential
for numerous applications in monoclonal antibody discovery
and engineering.
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